Advisor Group Holdings, Inc. Gossamer Bio, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 27,495 shares of GOSS stock, worth $31,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,495
Previous 1,349
1938.18%
Holding current value
$31,894
Previous $1,000
2900.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
162MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$21.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$21 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$11.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.34 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$7.38 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $109M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...